Navi Medical Technologies

Navi Medical Technologies is an Australian pediatric medtech company developing and commercializing devices for safer placement and monitoring of central venous access devices in newborns and children. Its lead product, the Neonav ECG Tip Location System, uses ECG-based tip location and surveillance technology to provide real-time catheter tip guidance during insertion and ongoing bedside monitoring after placement. The company focuses on neonatal and pediatric intensive care settings, where conventional catheter placement often relies on blind insertion followed by confirmatory X-ray. Neonav received U.S. FDA 510(k) clearance in February 2025, supporting Navi's entry into the U.S. market. Navi positions its technology as a first-of-its-kind pediatric-focused solution intended to improve safety, reduce complications from catheter misplacement or migration, and streamline vascular access workflows.